regular mouse diet (PMI Nutrition International LLC)
PMI Nutrition International LLC is a verified supplier 
PMI Nutrition International LLC manufactures this product 
95
Structured Review
PMI Nutrition International LLC
regular mouse diet
Regular Mouse Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 95/100, based on 84 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/regular+mouse+diet/PicoLab+Verified+75+IF+5V75/pm41547222-52-7-11
Average 95 stars, based on 84 article reviews
Regular Mouse Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 95/100, based on 84 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/regular+mouse+diet/PicoLab+Verified+75+IF+5V75/pm41547222-52-7-11
Average 95 stars, based on 84 article reviews
regular mouse diet - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Irradiation:Article Title: Prevention of aminoglycoside-induced outer hair cell loss by silencing CaMKKβ in an acute mouse model Article Snippet: Male CBA/J mice (stock #00656) and FVB/NJ breeder (stock #001800) at age of 4 weeks were purchased from the Jackson Laboratory. .. All mice had free access to a Article Title: Traumatic-noise-induced hair cell death and hearing loss is mediated by activation of CaMKKβ Article Snippet: Animals Male CBA/J mice (stock #00656) at the age of 10 weeks and FVB/NJ breeder mice (stock #001800) at the age of 4 weeks were purchased from the Jackson Laboratory. .. All mice had free access to water and a Article Title: Prevention of aminoglycoside-induced outer hair cell loss by silencing CaMKKβ in an acute mouse model. Article Snippet: The use of ototoxic drugs remains a common cause of acquired hearing loss worldwide.. Among them, aminoglycoside antibiotics are still widely used in clinical practice.. Although the pathological mechanisms underlying aminoglycoside-induced hearing loss have been extensively studied, no clinically effective pharmacological treatment is currently available to prevent such ototoxicity. Article Title: Prevention of noise-induced hearing loss by calpain inhibitor MDL-28170 is associated with upregulation of PI3K/Akt survival signaling pathway Article Snippet: Male CBA/J mice (stock #00656) at 10 weeks of age were purchased from The Jackson Laboratory. .. All mice had free access to water and a Article Title: Furosemide prevents noise-induced hearing loss and enhances the preventive effect of N-acetylcysteine. Article Snippet: Disruption of reactive oxygen species (ROS) homeostasis is a key mechanism underlying noise-induced sensory hair cell damage.. Antioxidant treatments such as N-acetylcysteine (NAC) have been shown to attenuate noiseinduced hearing loss (NIHL), supporting the role of ROS accumulation.. However, no FDA-approved pharmaceutical therapy currently exists for the prevention or treatment of NIHL, likely due to the complexity of the damaging mechanisms and the presence of the blood-labyrinth barrier (BLB), which limits drug permeability and prevents therapeutic compounds from reaching effective concentrations via systemic administration. Article Title: Prevention of noise-induced hearing loss by calpain inhibitor MDL-28170 is associated with upregulation of PI3K/Akt survival signaling pathway. Article Snippet: Male CBA/J mice (stock #00656) at 10 weeks of age were purchased from The Jackson Laboratory. .. All mice had free access to water and a Mouse Assay:Article Title: Furosemide prevents noise-induced hearing loss and enhances the preventive effect of N-acetylcysteine. Article Snippet: Disruption of reactive oxygen species (ROS) homeostasis is a key mechanism underlying noise-induced sensory hair cell damage.. Antioxidant treatments such as N-acetylcysteine (NAC) have been shown to attenuate noiseinduced hearing loss (NIHL), supporting the role of ROS accumulation.. However, no FDA-approved pharmaceutical therapy currently exists for the prevention or treatment of NIHL, likely due to the complexity of the damaging mechanisms and the presence of the blood-labyrinth barrier (BLB), which limits drug permeability and prevents therapeutic compounds from reaching effective concentrations via systemic administration. |